| Literature DB >> 33192217 |
Malgorzata Nita1, Andrzej Grzybowski2,3.
Abstract
Pathological biomolecules such as lipofuscin, methylglyoxal-modified proteins (the major precursors of advanced glycationend products), misfolding protein deposits and dysfunctional mitochondria are source of oxidative stress and act as strong autophagic stimulators in age-related macular degeneration. Disturbed autophagy accelerates progression of the disease, since it leads to retinal cells' death and activates inflammation by the interplay with the NLRP3 inflammasome complex. Vascular dysfunction and hypoxia, as well as circulating autoantibodies against autophagy regulators (anti-S100A9, anti-ANXA5, and anti-HSPA8, A9 and B4) compromise an autophagy-mediated mechanism as well. Metformin, the autophagic stimulator, may act as a senostatic drug to inhibit the senescent phenotype in the age-related macular degeneration. PGC-1α , Sirt1 and AMPK represent new therapeutic targets for interventions in this disease.Entities:
Keywords: age-related macular degeneration; autophagy; ophthalmology; oxidative stress; reactive oxygen species; retina disease
Year: 2020 PMID: 33192217 PMCID: PMC7658465 DOI: 10.17179/excli2020-2915
Source DB: PubMed Journal: EXCLI J ISSN: 1611-2156 Impact factor: 4.068
Figure 1A diagrammatic presentation of disturbed crosstalk between pathological excessiveness of reactive oxygen species and oxidative stress, and dysfunctional (insufficient) autophagy pathway in the aged AMD RPE cells